FOXA2 and hepatocellular carcinoma: In 2021, Huang H found that O‐GlcNAcylation, a newly discovered modification of FOXA2, might boost HCC cell migration by destabilizing FOXA2 and inhibiting the transcriptional activity of its downstream target gene E‐cadherin.167